Investment Memorandum · Preview
For informational purposes only. Not investment advice.
MP Materials Corp
MP
May 30, 2026
MP Materials owns and operates Mountain Pass (San Bernardino County, CA), the only commercially significant rare earth mine in the Western Hemisphere, with an estimated 7–8% TREO ore grade — well above the global 3–5% average. The company is executing a 6-year vertical integration: Stage 1 (mine + concentrator, operational since 2020); Stage 2 (NdPr oxide separation, commissioned 2024, producing 721 MT in Q3 2025); Stage 3 (NdFeB magnet manufacturing at Independence in Fort Worth, TX, ramping for GM deliveries, plus the 10X campus in Northlake, TX, targeting 10,000 MT/year by 2028). The July 2025 DoW partnership provided $400M in convertible preferred equity (plus up to $350M additional), a $150M loan for heavy rare earth separation, a 10-year NdPr price floor at $110/kg, and a 10-year offtake commitment for 100% of 10X output.
▲ Bull Case
- ◆Pillar 1: Western Hemisphere Quasi-Monopoly Is Durable. No credible US/Western competitor at scale exists on a commercially relevant timeline (5–10 years). Mountain Pass's geological grade advantage, permitting status, and operational history cannot be replicated in less than a decade. The DoW partnership formalizes this asset's strategic singularity.
- ◆Pillar 2: 5–10x Revenue Per Kg NdPr Via Vertical Integration. Moving from concentrate ($30–50/kg NdPr equivalent) to NdFeB magnets ($200–300/kg) multiplies value per unit of rare earth extracted. Stage 2 (oxide) is operational; Stage 3 (Independence) is ramping; 10X is the order-of-magnitude scale step.
- ◆Pillar 3: Government Backstop Removes the Worst Downside. DoW $110/kg NdPr price floor + 100% 10X offtake commitment for 10 years + $400M ($750M total committed) equity injection make the bear case bounded by execution risk, not commodity-price risk for committed volume.
▼ Bear Case
- ◆10X Execution Risk Is the Largest Single Variable. Large-scale industrial buildouts routinely run 15–35% over budget and 6–18 months late. A 12-month 10X delay defers ~$500M of FY2028–FY2029 EBITDA and could trigger refinancing needs. Construction inflation and labor cost pressures in 2026–2027 add genuine risk to the $1.25B disclosed cost.
- ◆The Stock Is Already Priced for the Bull Case. Reverse DCF shows the current $64.46 price embeds 10X EBITDA at bull-case ceiling ($830M required vs. $600M base), sustained NdPr realized prices ~$135–145/kg, and successful OEM expansion beyond GM. There is little margin for execution shortfall.
- ◆Commercial-Volume Pricing Is Cyclical Even With Floor. Only DoW-covered volume (estimated 2,500 MT/year of 3,500 MT total) gets the $110/kg floor. The residual 1,000 MT/year is exposed to China-spot cyclicality. A 2024-style NdPr trough to $50/kg would compress EBITDA by $40–60M and the ex-China premium thesis would face its first real test.
“Consensus is bullish (Strong Buy rating from S&P Global; 17 analysts; PT range $69–$100, average ~$76–80). The active debate among Street analysts is not whether the thesis is correct, but how aggressively to value 10X before construction milestones. Bulls (Goldman, JPMorgan) assign $4–6B in 10X NPV today on the basis of DoW offtake certainty. Conservatives (Barclays) assign $1–2B in 10X option value pending mid-2027 construction visibility. A secondary debate is whether the ex-China premium (~25–30%) is structural or cyclical. The non-consensus variant view is that 10X is worth $4–6B, not $500M — consistent with the bull thesis but argued from contractual cash flow certainty.”
- ◆Q2 2026 earnings: NdPr production sustains 700+ MT (August 2026)
- ◆HRE facility first Dy/Tb production (Mid-2026, Q3)
- ◆Additional non-GM OEM customer announcement (H2 2026–2027)
- ◆DoW $350M additional preferred tranche deployment (2026–2027)
- ◆10X construction milestone: structural steel completion (Mid-2027)
- ◆NdPr price sustain >$120/kg (Ongoing)
- ◆10X first commercial revenue (2028 — Major re-rating)
- ◆S&P 500 index inclusion possibility (2027–2028 if sustained >$15B market cap)
- ◆10X cost overrun (15–35%) — 50% probability, High severity
- ◆10X timeline delay 12+ months — 40% probability, High severity
- ◆Stage 2 production plateau <600 MT/Q — 30% probability, Medium severity
- ◆Magnet customer qualification delay (GM) — 40% probability, Medium severity
- ◆NdPr collapse to $50/kg (China spot) — 25% probability, Medium-Low severity
- ◆Mountain Pass operational shutdown — 10% probability, Very High severity
- ◆China-US rare earth trade deal — 10% probability, Very High severity
- ◆DoW price floor legally challenged — 5% probability, Very High severity
Full Memo Continues
5 more sections, locked
- ●Valuation Range & DCFBase/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
- ●Risk/Reward AssessmentPosition-sizing framework with explicit upside/downside skew and entry conditions.
- ●Management & Capital AllocationMulti-year capital-allocation track record, incentive alignment, and management readout.
- ●Monitoring FrameworkWhat to watch each quarter — leading indicators and inflection signals tracked by the analyst.
- ●Unresolved QuestionsOpen analyst questions and follow-up research items — the depth signal.
For Agents — $2 per memo
Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.
GET /api/v1/research/MP/memo Authorization: Bearer spt_...
Fund managers — coverage subscriptions launching soon. See marginofinsight.com.